Hypothalamic POMC Neurons in Prader-Willi Syndrome
Introduction <table class="infobox infobox-cell">Primary Location </td>Secondary Populations </td>Cell Type </td>Key Neurotransmitters </td>Primary Targets </td>Key Markers </td>Prohormone convertase 1/3 (PC1/3) </td>Prohormone convertase 2 (PC2) </td>Carboxypeptidase E </td>Peptidyl-α-amidating enzyme </td>Paternal deletion </td>
...
Hypothalamic POMC Neurons in Prader-Willi Syndrome
Introduction <table class="infobox infobox-cell">Primary Location </td>Secondary Populations </td>Cell Type </td>Key Neurotransmitters </td>Primary Targets </td>Key Markers </td>Prohormone convertase 1/3 (PC1/3) </td>Prohormone convertase 2 (PC2) </td>Carboxypeptidase E </td>Peptidyl-α-amidating enzyme </td>Paternal deletion </td>Maternal uniparental disomy (mUPD) </td>Imprinting center defect </td>Hyperphagia </td>Obesity </td>Growth hormone deficiency </td>Hypogonadism </td>Temperature dysregulation </td>Setmelanotide </td>Tirzepatide </td>Semaglutide </td>Fasting leptin </td>Insulin/glucose </td>α-MSH levels </td>NPY levels </td>
Pro-opiomelanocortin (POMC) neurons of the arcuate nucleus (ARC) are critical metabolic sensors that promote satiety and energy expenditure through the release of α-melanocyte-stimulating hormone (α-MSH). In Prader-Willi syndrome (PWS), hypothalamic POMC neuron dysfunction contributes to hyperphagia, obesity, and metabolic dysregulation. Understanding POMC neuron biology in PWS provides insights into broader neurodegenerative disease mechanisms, as hypothalamic dysfunction also occurs in Alzheimer's disease, Parkinson's disease, and [Huntington's disease](/diseases/huntingtons).
Neuroanatomy and Circuit Integration
POMC Neuron Location and Projections
Melanocortin System Architecture POMC neurons are the central anorexigenic component of the melanocortin system:
Mermaid diagram (expand to render)
Molecular Biology
POMC Gene and Peptide Processing The POMC gene encodes a precursor protein that undergoes tissue-specific processing:
Key Receptor Systems
Leptin receptor (LEPR) : Activates JAK-STAT signaling → POMC expressionInsulin receptor : PI3K-AKT pathway → glucose sensingSerotonin receptors (5-HT2C) : Lorcaserin mechanism (anti-obesity drug)Melanocortin-4 receptor (MC4R) : α-MSH target, autoinhibitory feedback
Downstream Signaling α-MSH binding to MC4R activates:
Gαs → cAMP → PKA : Anorexigenic signalingMAPK/ERK : Energy expenditureAutoinhibition : MC4R on POMC neurons provides feedback controlPrader-Willi Syndrome Mechanisms
Genetic Basis PWS results from loss of paternally expressed genes on chromosome 15q11-q13:
POMC Neuron Dysfunction in PWS The arcuate nucleus is developmentally affected in PWS:
Mermaid diagram (expand to render)
POMC Neurons in Neurodegenerative Disease
Alzheimer's Disease Hypothalamic dysfunction contributes to AD metabolic features:
Weight loss : Late-stage AD associated with hypothalamic atrophyPOMC neuron loss : Reduced arcuate nucleus neuron populationsLeptin resistance : Impaired leptin signaling in AD brainα-MSH neuroprotection : Melanocortins may reduce amyloid toxicityParkinson's Disease Metabolic changes in PD involve hypothalamic dysfunction:
Weight gain : Dopamine therapy, reduced olfaction → hyperphagiaPOMC changes : Altered α-MSH may contribute to weight dysregulationGhrelin elevation : Increased hunger signalingHypothalamic Lewy bodies : α-synuclein pathology in ARCHuntington's Disease Severe weight loss in HD despite hyperphagia:
Hypothalamic atrophy : Marked ARC degenerationPOMC loss : Reduced anorexigenic signaling paradoxHypermetabolism : Energy expenditure exceeds intakeCachexia : Terminal wasting despite food intakeAmyotrophic Lateral Sclerosis Metabolic dysfunction is a prognostic factor in ALS:
Hypermetabolism : 50% of ALS patientsHypothalamic changes : Altered neuropeptide expressionLeptin reduction : Associated with disease progressionLipid metabolism : Hypothalamic regulation affectedTherapeutic Targets
MC4R Agonists
PWS-Specific Therapies
Growth hormone : Standard of care, may indirectly affect POMCOxytocin : Trials for hyperphagia (hypothalamic target)Intranasal insulin : May improve hypothalamic signalingMC4R agonists : Under investigation for PWS hyperphagia
Gene Therapy Prospects
SNRPN/NDN replacement : Theoretically possible for paternal deletionCRISPR activation : Reactivate maternal alleles (imprinted genes)Hypothalamic stem cells : Potential for POMC neuron replacementClinical Assessment
Imaging
Hypothalamic MRI : Volume assessment in PWSFunctional MRI : Response to food cuesPET imaging : Hypothalamic metabolism[Neurons — Major brain cell type](/cell-types/neurons)](/entities/neurons)
[Glia — Support cells in the brain](/genes/th)
[Alzheimer's Disease — Related neurodegenerative disease](/genes/rel)
[Parkinson's Disease — Related neurodegenerative disease](/genes/ar)
External Links
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
Show full description